Arigato Osaka
From May 18th to 24th, we joined the Italy Pavilion at Expo Osaka 2025 as part of an initiative promoted by Lazio Innova, contributing to the dialogue on biotechnology at a global level.
Our participation allowed us to engage with international researchers and institutions, confirming the global relevance of our approach to personalized medicine.
The working sessions organized by Regione Lazio Lazio facilitated direct dialogue between companies and public stakeholders.
We contributed to the definition of guidelines for future regional funding, with a focus on the concrete needs of biotech R&D.
During our visit to Tokyo Innovation Base, we observed how Japanese institutions foster biotech collaboration by integrating startups, researchers, and established companies.
This approach offered insights we can apply to strengthen our own collaborative models.
Throughout the event, we registered significant interest in our platforms for genetic vaccines and monoclonal antibodies.
These exchanges laid the groundwork for potential partnerships aimed at accelerating our programs and broadening our scientific reach.
We return to Rome with concrete opportunities to advance our research through international collaboration: a sign that Italian biotechnology is ready to contribute to global progress in life sciences.
